Primary chemotherapy with doxorubicin and paclitaxel in patients with early breast cancer: final results of a multicenter phase II study

被引：0
作者：
P. Schmid
J. Krocker
G. Morack
V. Heilmann
J.-U. Blohmer
K. Michniewicz
G. Köhler
T. Schaller-Kranz
K. Possinger
D. Elling
机构：
[1] Humboldt University Berlin,Medizinische Klinik II, Department of Oncology and Hematology, Charité Campus Mitte
[2] Oskar-Ziethen-Krankenhaus,Frauenklinik
[3] Frauenklinik Buch,Klinik für Gynäkologie und Geburtshilfe, Charité Campus Mitte
[4] Universitätsfrauenklinik,Frauenklinik
[5] Humboldt Universität zu Berlin,undefined
[6] Ernst-Moritz-Arndt Universität,undefined
[7] Bristol Myers Squibb,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2004年 / 130卷
关键词：
Primary chemotherapy; Neoadjuvant; Early breast cancer; Paclitaxel; Doxorubicin; Adjuvant treatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：657 / 663
页数：6
相关论文
共 50 条
[21]   A phase-III trial of doxorubicin and docetaxel versus doxorubicin and paclitaxel in metastatic breast cancer: results of the ERASME 3 study [J].
Philippe A. Cassier ;
Sylvie Chabaud ;
Véronique Trillet-Lenoir ;
Pierre-Yves Peaud ;
Jean-Dominique Tigaud ;
Hervé Cure ;
Hubert Orfeuvre ;
Bruno Salles ;
Claude Martin ;
Jean-Philippe Jacquin ;
Cecile Agostini ;
Jean-Paul Guastalla ;
David Pérol ;
Thomas Bachelot .
Breast Cancer Research and Treatment, 2008, 109 :343-350
[22]   A phase-III trial of doxorubicin and docetaxel versus doxorubicin and paclitaxel in metastatic breast cancer:: results of the ERASME 3 study [J].
Cassier, Philippe A. ;
Chabaud, Sylvie ;
Trillet-Lenoir, Veronique ;
Peaud, Pierre-Yves ;
Tigaud, Jean-Dominique ;
Cure, Herve ;
Orfeuvre, Hubert ;
Salles, Bruno ;
Martin, Claude ;
Jacquin, Jean-Philippe ;
Agostini, Cecile ;
Guastalla, Jean-Paul ;
Perol, David ;
Bachelot, Thomas .
BREAST CANCER RESEARCH AND TREATMENT, 2008, 109 (02) :343-350
[23]   Preoperative Carboplatin–Paclitaxel–Bevacizumab in Triple-Negative Breast Cancer: Final Results of the Phase II Ca.Pa.Be Study [J].
Valentina Guarneri ;
Maria Vittoria Dieci ;
Giancarlo Bisagni ;
Corrado Boni ;
Katia Cagossi ;
Fabio Puglisi ;
Annarita Pecchi ;
Federico Piacentini ;
PierFranco Conte .
Annals of Surgical Oncology, 2015, 22 :2881-2887
[24]   A phase II study of paclitaxel/cisplatin combination in patients with metastatic breast cancer refractory to anthracycline-based chemotherapy [J].
Rosati, G ;
Riccardi, F ;
Tucci, A ;
De Rosa, P ;
Pacilio, G .
TUMORI, 2000, 86 (03) :207-210
[25]   High efficacy of paclitaxel and doxorubicin as first-line therapy in advanced breast cancer: A phase I-II study [J].
De Lena, M ;
Latorre, A ;
Calabrese, P ;
Catino, A ;
Lorusso, V ;
Mazzei, A ;
Aloe, A .
JOURNAL OF CHEMOTHERAPY, 2000, 12 (04) :367-373
[26]   Final results of a phase II study of paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer [J].
J. Salvador ;
L. Manso ;
J. de la Haba ;
A. Jaen ;
E. Ciruelos ;
M. C. de Villena ;
M. Gil ;
A. Murias ;
A. Galan ;
C. Jara ;
J. Bayo ;
J. M. Baena ;
J. Casal ;
J. R. Mel ;
I. Blancas ;
P. Sanchez Rvira .
Clinical and Translational Oncology, 2015, 17 :160-166
[27]   Final results of a phase II study of paclitaxel, bevacizumab, and gemcitabine as first-line therapy for patients with HER2-negative metastatic breast cancer [J].
Salvador, J. ;
Manso, L. ;
de la Haba, J. ;
Jaen, A. ;
Ciruelos, E. ;
de Villena, M. C. ;
Gil, M. ;
Murias, A. ;
Galan, A. ;
Jara, C. ;
Bayo, J. ;
Baena, J. M. ;
Casal, J. ;
Mel, J. R. ;
Blancas, I. ;
Sanchez Rvira, P. .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2015, 17 (02) :160-166
[28]   Long-term results from a phase II study of paclitaxel combined with doxorubicin in recurrent platinum refractory ovarian cancer [J].
Tropé, C ;
Kristensen, G ;
Kisic, J ;
Kaern, J .
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2001, 22 (03) :223-227
[29]   A Phase II Trial of Neoadjuvant Chemotherapy with Genexol® (Paclitaxel) and Epirubicin for Locally Advanced Breast Cancer [J].
Lee, Jinsun ;
Kim, Jeryong ;
Chang, Eilsung ;
Choi, Woonjung ;
Lee, Kwangman ;
Yoon, Hyunjo ;
Jung, Sunghoo ;
Park, Minho ;
Yoon, Junghan ;
Kim, Sungyong .
JOURNAL OF BREAST CANCER, 2014, 17 (04) :344-349
[30]   A dose-dense schedule of docetaxel followed by doxorubicin and cyclophosphamide as neoadjuvant treatment for breast cancer: results from a phase II study [J].
Antolin, Silvia ;
Mel, Ramon ;
Ramos, Manuel ;
Garcia-Palomo, Andres ;
Almanza, Concepcion ;
de Paz, Laura ;
Calvo, Lourdes ;
Alvarez, Elena ;
Gonzalez, Ana ;
Garcia-Mata, Jesus .
CLINICAL & TRANSLATIONAL ONCOLOGY, 2011, 13 (09) :686-691
12345